Brief communication| Volume 48, ISSUE 5, P591-596, December 01, 1987

The effect of molecular weight on the bioavailability of heparin

      This paper is only available as a PDF. To read, Please Download here.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Thrombosis Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Kakkar V.
        Prevention of post-operative venous thromboembolism by a new low molecular weight heparin.
        Nouv. Rev. Fr. Hematol. 1984; 26: 277-282
        • Bergqvist D
        • Hedner U
        • Sjorn E
        • Holmer E.
        Anticoagulant effects of two types of low molecular weight heparin administered subcutaneously.
        Thromb. Res. 1983; 32: 381-391
        • Fareed J
        • Walenga J
        • Williamson K
        • Emanuele M
        • Kumar A
        • Hoppensteadt D.
        Studies on the antithrombotic effects and pharmacokinetics of heparin fractions and fragments.
        Sem. Thromb. Hemost. 1985; 11: 56-74
        • Salzman E.
        Low molecular weight heparin Is small beautiful?.
        N. Engl. J. Med. 1986; 315: 957-959
        • Harenberg J
        • Wurzner B
        • Zimmermann R
        • Schettler G.
        Bioavailability and antagonization of the low molecular weight heparin CY 216 in man.
        Thromb. Res. 1986; 44: 549-554
        • Bentley P
        • Kakkar V
        • Scully M
        • Mac Gregor F
        • Webb F
        • Chan P
        • Jones H.
        An objective study of alternative methods of heparin administration.
        Thromb. Res. 1980; 18: 177-187
        • Harenberg J
        • De Vries J.
        Characterization of heparins by high performance size exclusion liquid chromatography.
        J. Chromatog. 1983; 261: 287-292
      1. Heptest Package Insert. Haemachen, Inc. St. Louis, MO 1985.